Alerts will be sent to your verified email
Verify Email
PGHL
|
Procter&Gamble Healt
|
Sanofi India
|
Strides Pharma Scien
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Pharmaceuticals
|
|||
|
Domestic Sales Growth - YoY
|
20.1 % | 1.7 % | n/a |
|
Financials
|
|||
|
5 yr Average ROE
|
36.03 % | 52.02 % | 23.7 % |
|
5yr average Equity Multiplier
|
1.79 | 4.62 | 2.62 |
|
5yr Average Asset Turnover Ratio
|
0.77 | 0.47 | 0.6 |
|
5yr Avg Net Profit Margin
|
19.19 % | 24.38 % | 12.9 % |
|
Price to Book
|
18.82 | 12.8 | 3.29 |
|
P/E
|
33.63 | 26.66 | 22.84 |
|
5yr Avg Cash Conversion Cycle
|
-155.74 Days | 4.83 Days | -51.45 Days |
|
Inventory Days
|
36.01 Days | 66.8 Days | 69.05 Days |
|
Days Receivable
|
40.92 Days | 31.98 Days | 60.35 Days |
|
Days Payable
|
215.28 Days | 63.37 Days | 225.58 Days |
|
5yr Average Interest Coverage Ratio
|
500.05 | 906.11 | 0.72 |
|
5yr Avg ROCE
|
30.21 % | 27.19 % | 10.5 % |
|
5yr Avg Operating Profit Margin
|
27.53 % | 24.71 % | 12.17 % |
|
5 yr average Debt to Equity
|
0.0 | 0.0 | 1.01 |
|
5yr CAGR Net Profit
|
4.02 % | 31.63 % | 68.01 % |
|
5yr Average Return on Assets
|
15.5 % | 11.5 % | 10.97 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
51.82 % | 60.4 % | 27.86 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 44.13 % |
|
Change in Promoter Holding (3 Yrs)
|
-0.03 % | 0.0 | -3.21 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
3.66 % | 0.97 % | 0.16 % |
|
Procter&Gamble Healt
|
Sanofi India
|
Strides Pharma Scien
|
|
|---|---|---|---|
|
Segment Break-Up
|
Segment Break-Up
|
-
|
-
|
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
|
Drug Delivery Break-Up
|
Drug Delivery Break-Up
|
-
|
-
|
|
Therapeutic Area Break-Up
|
Therapeutic Area Break-Up
|
-
|
-
|
|
Asset Break-Up
|
Asset Break-Up
|
-
|
Asset Break-Up
|